Swedish Pharmaceuticals & Biotech High Growth Potential Companies

Camurus

Market Cap: SEK 30.7b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bonesupport Holding

Market Cap: SEK 15.8b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Guard Therapeutics International

Market Cap: SEK 25.8m

A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.

Initiator Pharma

Market Cap: SEK 201.9m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Ascelia Pharma

Market Cap: SEK 391.3m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Lipigon Pharmaceuticals

Market Cap: SEK 1.4m

A clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.5b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

Genovis AB (publ.)

Market Cap: SEK 1.4b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Egetis Therapeutics

Market Cap: SEK 3.1b

A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.

AlzeCure Pharma

Market Cap: SEK 167.8m

Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

Moberg Pharma

Market Cap: SEK 517.0m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Magle Chemoswed Holding

Market Cap: SEK 115.0m

Engages in research and development of pharmaceutical and medical device products in Sweden.

Vitrolife

Market Cap: SEK 14.2b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

BioInvent International

Market Cap: SEK 1.5b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.

BioGaia

Market Cap: SEK 13.3b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

SynAct Pharma

Market Cap: SEK 796.3m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Swedish Orphan Biovitrum

Market Cap: SEK 151.7b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Swedencare

Market Cap: SEK 4.0b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

AddLife

Market Cap: SEK 17.9b

Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.

Active Biotech

Market Cap: SEK 164.5m

A biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden.

MedCap

Market Cap: SEK 8.2b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.